Device has one of the most valuable relationships with the patient.
Because the patient is always on.
A data-rich opportunity.
Legacy device, though, usually has an episodic relationship with patients.
Whereas pharma has had a longer-term, in some cases lifetime, relationship with patients. A subscription model, if you will.
The convergence of pharma, medtech, wearables, and RPM creates a massive opportunity in healthcare.
Who makes the moves to capitalize on this?